Search clinical trials for: Zetiq CellDetect ® stain

Total 20616 results

University of Malaya

Completed

Efficacy and Safety Study of Lamotrigine to Treat Trigeminal Neuralgia

Trigeminal Neuralgia

Malaysia
Aesculap AG

Active, not recruiting

Post Market Clinical Follow-Up of Plasmafit® Cup

Total Hip Arthroplasty

Germany
Fresenius Kabi SwissBioSim GmbH

Completed

MSB11456 in Participants With Moderately to Severely Active Rheumatoid Arthritis

Rheumatoid Arthritis

Hungary, Serbia, Georgia, Russian Federation, Slovakia, Czechia, Bulgaria, Moldova, Republic of, Poland
Global Kinetics Corporation

Withdrawn

Utilization of Target Ranges to Treat Persons With Parkinson's Disease by Objective Measurement Using the PKG (TARGET-PwP)

Parkinson Disease
Janssen Inc.

Completed

Biologic Treatment Registry Across Canada (BioTRAC)

Arthritis, Rheumatoid | Arthritis, Psoriatic | Spondyloarthritis, Axial

Canada
Ophthotech Corporation

Completed

A Study to Establish the Safety and Tolerability of Zimura® (Anti-C5 Aptamer) in Combination With Anti-VEGF Therapy in Subjects With Idiopathic Polypoidal Choroidal Vasculopathy (IPCV)

Idiopathic Polypoidal Choroidal Vasculopathy

United States
Herlev and Gentofte Hospital

Recruiting

Pyrocardan® Implant Arthroplasty or LRTI for Trapeziometacarpal Osteoarthritis

Trapeziometacarpal Osteoarthritis | CMC-1 Osteoarthritis

Denmark
Celgene

Active, not recruiting

Connect® MM- The Multiple Myeloma Disease Registry

Multiple Myeloma

United States, Puerto Rico
University of California, Los Angeles

Active, not recruiting

Pneumococcal Conjugate Vaccine 13 (Prevnar13®) in Children Who Are Solid Organ Transplant Recipients (SOT)

Infection in Solid Organ Transplant Recipients

United States
InnoRa GmbH

Terminated

Safety and Tolerance of the Use of InnoCath AB® Hyper-compliant Balloon (HYPER)

Lesions in the Superficial Femoral Artery and/or Popliteal Artery Pars I/II

Germany
Lantheus Medical Imaging

Completed

A Study to Evaluate the Use and Safety of CARDIOLITE® in Pediatric Patients With Kawasaki Disease

Kawasaki Disease

United States, Brazil, Canada, Taiwan, Philippines, Thailand, Korea, Republic of
Taewoong Medical Co., Ltd.

Terminated

Effectiveness and Safety Confirmation Between FASTSEAL® Bioabsorbable VCD and Perclose® ProGlide SMC System

The Patients Who Needed Hemostasis at the Puncture Site of Common Femoral Artety(CFA) Caused by Femoral Angiogram or Intervention After the Catheter Removal

Korea, Republic of
Berlin Heart, Inc

Completed

Assess Safety and Probable Benefit of the EXCOR® Pediatric Ventricular Assist Device

Heart Failure | Cardiomyopathies

Canada, United States
Natural Orifice Surgery Consortium for Assessment...
American Society for Gastrointestinal Endoscopy

Unknown

Prospective Multicenter Human Randomized Controlled Evaluation of NOTES® Cholecystectomy

Gall Bladder Diseases

United States
Washington University School of Medicine
Genomic Health®, Inc.

Recruiting

Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score

Breast Cancer | Breast Neoplasms | Cancer of Breast | Cancer of the Breast

United States
Sanofi Pasteur, a Sanofi Company

Completed

Anti-Hep B Antibodies at Age 9 to 10 Years After Hep B Vaccine at Birth and DTaP-IPV-Hep B-PRP-T Hexavalent Vaccine.

Hepatitis B

Thailand
Gedeon Richter Plc.

Completed

Comparative Efficacy and Safety Study of RGB-14-P and Prolia® in Women With Postmenopausal Osteoporosis

Postmenopausal Osteoporosis

Poland, United States, Spain, Hungary, Italy, Czechia, Bulgaria, Ukraine
UCB Pharma GmbH

Completed

Observational Study With Neupro® to Evaluate the Patient´s Perception of Pain Associated With Parkinson´s Disease (NEUPAD)

Idiopathic Parkinson's Disease

Germany, Austria
Sanofi Pasteur, a Sanofi Company

Completed

A Study to Evaluate the Safety and Immune Responses to Fluzone® Vaccination

Influenza

United States
Sanofi Pasteur, a Sanofi Company

Completed

Phase IV Trial to Collect Safety Data and Sera in Healthy Children Given Fluzone Vaccine

Influenza

United States
UCB Pharma

Completed

A Trial to Investigate Safety and Efficacy of SPM927 in Painful Diabetic Neuropathy

Painful Diabetic Neuropathy
UCB Pharma

Completed

An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Early-Stage Parkinson's Disease

Early Stage Parkinson's Disease

Poland, United Kingdom, Germany, Spain, Switzerland, Belgium, South Africa, New Zealand, Czech Republic, Austria, Hungary, Australia, Italy, Israel, Sweden, Norway, Croatia, Netherlands, Finland, France
UCB Pharma

Completed

An Open-Label Extension Trial to Assess the Safety and Tolerability of Long Term Treatment of Rotigotine in Subjects With Idiopathic Parkinson's Disease

Idiopathic Parkinson's Disease

United States, Germany, Spain, Austria, Israel, Italy, South Africa, United Kingdom
UCB Pharma

Completed

Belgian Drug-utilization Study to Evaluate the Use of VIMPAT® as Adjunctive Treatment of Partial Onset Seizures in Subjects Aged 16 and Older

Seizures

Belgium
Azidus Brasil
Cellavita Pesquisa Científica Ltda

Not yet recruiting

Efficacy and Safety of NestaCell® in Huntington's Disease (STAR)

Huntington Disease
UCB Pharma

Completed

An Open-label follow-on Trial to Assess the Long-term Safety and Efficacy of Oral SPM 927 in Subjects With Diabetic Neuropathy

Painful Diabetic Neuropathy
Orient Pharma Co., Ltd.
Durect

Completed

Evaluate Long-term Safety and Efficacy of ORADUR®-Methylphenidate in Children and Adolescents With ADHD

Attention Deficit Hyperactivity Disorder

Taiwan
Fresenius Kabi SwissBioSim GmbH

Completed

MSB11022 in Healthy Subjects

Healthy Subjects
Yuyu Pharma, Inc.

Completed

Pharmacokinetics of Maxmarvil® in Healthy Postmenopausal Women (YY_PK_2011)

Osteoporosis

Korea, Republic of
UCB Pharma

Completed

An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Advanced-Stage Parkinson's Disease

Advanced Stage Parkinson's Disease

France, Italy, Poland, United Kingdom, Spain, Germany, South Africa, New Zealand, Czech Republic, Hungary, Australia, Austria, Israel, Sweden, Norway, Croatia, Finland
ONIRIS

Completed

Mandibular Advancement Devices Tali® in Patients With Syndrome of Obstructive Sleep Apnea and Hypopneas

Syndrome of Obstructive Sleep Apnea and Hypopneas

France
Enzymotec

Completed

Vayarin® Medical Food Study for Adults With Attention Deficit Hyperactivity Disorder (ADHD)

Attention Deficit Hyperactivity Disorder (ADHD)

United States
Veloxis Pharmaceuticals

Approved for marketing

Expanded Access Study for Renal Transplant Patients With Envarsus XR ™

Renal Failure
ANM Adaptive Neuromodulation GmbH
CERES GmbH

Completed

Acoustic Coordinated Reset (CR®) Neuromodulation for the Treatment of Chronic Tonal Tinnitus ("RESET Real Life") (RRL)

Tinnitus

Germany
Sanofi Pasteur, a Sanofi Company

Completed

Persistence of Bactericidal Antibodies in Adolescents and Adults Who Had Received a Single Dose of Menactra® Vaccine

Meningitis | Meningococcal Infections

United States
Bayer

Completed

Low-dose Nifedipine-Valsartan Combination Compared to Up-titrated Valsartan Monotherapy in Essential Hypertension

Hypertension

China, Korea, Republic of
Astellas Scientific & Medical Affairs, Inc.

Completed

A Prospective, Observational, Multicenter Study of Patients Following Initiation of a New Course of Treatment for Overactive Bladder (OAB) (PERSPECTIVE)

Urologic Diseases | Overactive Bladder | Urinary Bladder Diseases | Urinary Bladder Overactive

United States, Canada
Ipsen

Terminated

Dysport in Vulvodynia Phase II Study (DYVINIA)

Vulvodynia

United States, Canada
University of Zurich

Withdrawn

Clevidipine (Cleviprex®) Compared With Urapidil (Ebrantil®) (Clevidipine)

Nontraumatic Intracerebral Hemorrhage, Multiple Localized

Switzerland
University Hospital, Basel, Switzerland

Recruiting

Hyperinsulinemia in Prediabetes Mediated by Interleukin-1β (Hyper-PreDIL)

PreDiabetes | Hyperinsulinemia

Switzerland
Geistlich Pharma AG
TigerMed

Recruiting

Chondro-Gide® Bilayer Collagen Membrane in Knee Cartilage Defect Repair

Cartilage Defects

China
UCB Pharma

Completed

A Multi-Centre, Randomized, Double-Blind, Placebo Controlled Pilot Trial to Assess the Efficacy, Safety, and Tolerability of SPM 927 in Subjects With Postherpetic Neuralgia (PHN).

Postherpetic Neuralgia
Orient Pharma Co., Ltd.
Durect

Completed

Evaluate Safety and Efficacy of ORADUR®-Methylphenidate in Children and Adolescents With ADHD

Attention Deficit Hyperactivity Disorder

Taiwan
UCB Pharma

Completed

Study in Healthy Volunteers to Prove That Two Rotigotine Patches From Different Manufacturing Sites Deliver Equivalent Drug Amount to the Body

Healthy Volunteers

Germany
UCB Pharma

Completed

Named Patient Program With Rotigotine Transdermal System

Conditions for Which There is a Documented Medical Necessity to Receive Treatment With Rotigotine

United States
UCB Pharma

Completed

Long-term Open-label Trial in Idiopathic Restless Legs Syndrome (RLS)

Restless Legs Syndrome

Germany, Spain, Austria
Ethicon, Inc.

Recruiting

GYNEMESH PS Mesh Post Marketing Clinical Follow-Up Study

Pelvic Organ Prolapse

United States, Germany
Bristol-Myers Squibb

Active, not recruiting

A Study to Compare the Response to Treatment With Abatacept vs Adalimumab, on Background Methotrexate, in Adults With Early, Seropositive, and Shared Epitope-positive Rheumatoid Arthritis and an Inadequate Response to Methotrexate

Rheumatoid Arthritis

Italy, United States, Germany, Argentina, Australia, Czechia, France, Japan, Mexico, Poland, Spain, Switzerland, Taiwan, United Kingdom
University Hospital, Basel, Switzerland

Completed

Neoveil® Versus TachoSil® for the Treatment of Pulmonary Air Leaks Following Lung Operation

Prolonged Air Leak | Postoperative Air Leak

Switzerland
FeetMe

Completed

Validation Study : FeetMe® Monitor Insoles for the Evaluation of Gait Speed

Healthy

France

Search clinical trials for: Zetiq CellDetect ® stain

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Australia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations